性欧美视频69_在线播放观看av_Av在线无码网址_在线五月丁香婷啪AV

歡迎光臨! 當前位置： 首頁 > 詳細內(nèi)容

<%=currentDocument.Title%> PDF

不對稱催化反應(yīng)大多屬于均相催化反應(yīng)，其催化的效率通常用對映體過量百分率ee％表示。近年來，不對稱催化技術(shù)得到迅速發(fā)展。

銠的膦配體作為不對稱催化反應(yīng)常用配體，具有反應(yīng)條件溫和、反應(yīng)選擇性高等特點，因此被廣泛應(yīng)用于石油化工、醫(yī)藥化工、精細化工等領(lǐng)域。

國際知名品牌美國STREM工廠研發(fā)生產(chǎn)的套包裝catASium ®催化劑和配體產(chǎn)品極具競爭優(yōu)勢，可增加收率，縮短反應(yīng)時間及減少三廢。

2008年，百靈威與STREM 正式簽署戰(zhàn)略合作協(xié)議，全權(quán)負責STREM 在中國市場的產(chǎn)品銷售、技術(shù)應(yīng)用與支持等各項業(yè)務(wù)。百靈威始終秉承“資源共享，共同發(fā)展”之理念，一如既往地為中國化學(xué)行業(yè)廣大科研和生產(chǎn)用戶提供品質(zhì)卓越的化學(xué)相關(guān)產(chǎn)品及服務(wù)，為實現(xiàn)“促進科技與工業(yè)發(fā)展，造福人類”的使命而不懈努力！

96-6655 Solvias catASium® Catalyst and Ligand Kit for Asymmetric Hydrogenation！

96-6655            Solvias catASium® Catalyst and Ligand Kit for Asymmetric Hydrogenation                  1 kit    
                          Contains 100mg unit of the catASium® items listed on page 1

(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]maleic anhydride,min.97%[catASium®M(R)]
[505092-86-4]
C16H24O3P2; FW: 326.31; brown pwdr. air sensitive
Note: Sold in collaboration with Solvias for research purposes only. Patent WO 03084971.
Technical Note: 1. See 45-0173.
100mg
500mg
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-(3,5-dimethylphenyl)-1H-pyrrole-2,5-dione, min. 97%[catASium® MNXyl)]
C24H33NO2P2; FW: 429.47; white pwdr.
100mg
500mg
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-[3,5-bis(trifluoromethyl)phenyl]-1H-pyrrole-2,5-dione, min. 95% [catASium ® MNXylF(R)]
C24H27F6NO2P2; FW: 537.42; white pwdr.
100mg
500mg
(3R,4R)-(+)-Bis(diphenylphosphino)-1-benzylpyrrolidine, min. 98% [catASium® D(R)] [99135-95-2]
C35H33NP2; FW: 529.59; white pwdr.; m.p. 120/; [α]D +93.6/ (c 1.0, CHCl3) air sensitive
Note: Sold in collaboration with Solvias for research purposes only. Patent EP 151282.
Technical Notes:
 1. Enantioselective catalyst for the hydrogenation of Z-2-acetamidocinnamic acid.
 2. Highly enantioselective catalyst for asymmetric reductive amination.
100mg
500mg
(+)-{(1S,4R)-3-[4-(Diphenylphosphino)-2,5-dimethyl-3-thienyl)-4,7,7-trimethylbicyclo[2.2.1]hept-2-en-2-yl}diphenylphosphine, min. 96% [catASium®T1] [868851-47-2]
C40H40P2S; FW: 614.76; white pwdr.
100mg
500mg
(+)-{4-[(1R,4S)-3-(Diphenylphosphino)-1,7,7-trimethylbicyclo[2.2.1]hept-2-en-2-yl]-2,5-dimethyl-3-thien-3-yl}bis(3,5-dimethylphenyl)phosphine, min. 95% [catASium®T3] [868851-50-7]
C44H48P2S; FW: 670.87; white pwdr.
100mg
500mg
(+)-{(1S,4R)-3-[4-(Diphenylphosphino)-2,5-dimethyl-3-thienyl]-4,7,7-trimethylbicyclo[2.2.1]hept-2-en-2-yl}bis(3,5-dimethylphenylphosphine, min. 98% [catASium® T2]
C44H48P2S; FW: 670.87; white to yellow pwdr.; [a]D +99.1/ (c 1.0, CHCl3) air sensitive
Note: Optical purity 97+%
Sold in collaboration with Solvias for research purposes only. Patent No. EP 04011152.8.
Technical Note:
 1. Highly enantioselective catalyst for the hydrogenation of α- and β-acylamido acrylates or less functionalized olefins under mild conditions.
100mg
500mg
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]maleic anhydride(1,5-cyclooctadiene)r hodium (I) tetrafluoroborate, 98% [catASium® M(R)Rh] [507224-99-9]
Rh(C8H12)(C16H24O3P2)+BF4-; FW: 624.20; red-brown pwdr. air sensitive
Note: Optical purity 96%
Sold in collaboration with Solvias for research purposes only. Patent WO 03084971.
Technical Notes:
 1. Highly enantioselective catalyst for the hydrogenation of E or Z β-acylamido acrylates          under mild conditions and low pressure.
 2. Highly enantioselective for the hydroge nation of itaconates at room temperature.
100mg
500mg
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-methyl-1H-pyrrole-2,5-dione(1,5-cyclooctadiene)rhodium (I) tetrafluoro-borate, min. 97% [catASium® MN(R)Rh]
Rh(C8H12)(C17H27NO2P2)+BF4-; FW: 637.24; red-orange pwdr. air sensitive
Note: Optical purity 95%
Sold in collaboration with Solvias for research purposes only. Patent WO 03084971.
Technical Note:
 1. See 45-0173.
100mg
500mg
(3R,4R)-(+)-Bis(diphenylphosphino)-1-benzylpyrrolidine(1,5-cyclooctadiene)rhodium (I) tetrafluoroborate, min. 97% [catASium ® D(R)Rh] [99143-48-3]
Rh(C8H12)(C35H33NP2)+BF4-; FW: 827.49; yellow pwdr. air sensitive
Note: Optical purity min. 97%
Sold in collaboration with Solvias for research purposes only. Patent EP 151282.
Technical Note:
1. See 15-0135.
100mg
500mg
(-)-3,4-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-benzyl-1H-pyrrole-2,5-dione(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate, min. 95% [catASium® MNBn(R)Rh]
Rh(C8H12)(C23H31NO2P2)+ BF4-; FW: 713.34; orange pwdr.
100mg
500mg
(-)-3,4-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-pentafluorophenyl-1H-pyrrole-2,5-dione(1,5-cyclooctadiene) rhodium(I) tetrafluoroborate, min. 95% [catASium®MNF(R)Rh]
Rh(C 8H12)(C22H24F5NO2P2)+ BF4-; FW: 789.26; orange pwdr.
100mg
500mg
(-)-4,5-Bis[(2R,5R)-2,5-dimethylphospholanyl](1,2-dimethyl-1,2-dihydropyridazine-3,6-dione)(1,5-cyclooctadiene)rhodium (I) tetrafluorobor ate, min. 95% [catASium® MNN(R)Rh]
Rh(C8H12)(C18H30N2O2P2)+BF4-; FW: 666.28; orange-brown pwdr.air sensitive
Note: Sold in collaboration with Solvias for research purposes only. Patent WO 03084971.
Technical Note:
 1. See 45-0173.
100mg
500mg
(-)-1,2-Bis[(2R,5R)-2,5-dimethylphospholanyl]-3,3,4,4-tetrafluoro-1-cyclobutene(1,5-cyclooctadiene)rhodium (I)tetrafluoroborate, min. 95% [catASium® MQF(R)Rh]
Rh(C8H12)(C16H24F4P2)+BF4-; FW: 652.19; orange to brown pwdr.
100mg
500mg
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-[3,5-bis(trifluoromethyl)phenyl]-1H-pyrrole-2,5-dione(1,5-cyclooctadiene)rhodium (I) tetrafluoroborate, min. 97% [catASium® MNXylF(R)Rh]
Rh(C8H12)(C24H27F6NO2P2)+BF4-; FW: 835.31; red to dark red solid air sensitive
Note: Sold in collaboration with Solvias for research purposes only. Patent WO 03084971.
Technical Note:
 1. See 45-0173.
100mg
500mg
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-[3,5-dimethylphenyl]-1H-pyrrole-2,5-dione(1,5-cyclooctadiene)rhodium (I) tetrafluoroborate, min. 97% [catASium®MNXyl(R)Rh]
Rh(C8H12)(C24H33NO2P2)+BF4-; FW: 727.36; red-brown solid air sensitive
Note: Sold in collaboration with Solvias for research purposes only. Patent WO 03084971.
Technical Note:
 1. See 45-0173.
100mg
500mg
(-)-2,3-Bis[(2R,5R)-2,5-dimethylphospholanyl]-1-[4-methoxyphenyl]-1H-pyrrole-2,5-dione(1,5-cyclooctadiene)rhodium (I) tetrafluorobor ate, min. 97% [catASium® MNAn(R)Rh]
Rh(C8H12)(C23H31NO3P2)+BF4-; FW: 729.34; orange pwdr. air sensitive
Note: Sold in collaboration with Solvias for research purposes only. Patent WO 03084971.
Technical Note:
 1. See 45-0173.
100mg
500mg

第1頁 總共1頁